“What a Headache!” (or Maybe Not): 2021 Migraine Treatment Updates
“What a Headache!” (or Maybe Not): 2021 Migraine Treatment Updates
12% of adults experience disabling migraines. Fortunately, there are multiple new medications. Take this course to learn about the new medications and how providers select which medication to prescribe.
Upon successful completion of this knowledge-based CPE course, pharmacy technicians should be able to:
1. List the brand/generic names and indication(s) of new drugs approved for treatment of migraines
2. Define the following terms: aura, medication overuse headache, medication-use headache
3. Explain the factors impacting the selection of therapies for migraines
Nicholas Cox, PharmD, BCACP
Assistant Professor
University of Utah
Nicholas Cox does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course.
Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: September 1, 2021
Planned Expiration Date: September 1, 2024
Copyright 2021, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.
CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.
¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.
Additional information
| Duration | 0h 45m |
|---|---|
| Topic Designator | Disease State/Drug Therapy |
| ACPE | Yes |
| ACPE Topic | |
| Role | Technician |
| Media-Type | On-Demand |
| Release Date | 9/1/21 |
| CEUs | 0.075 |
| Rating | 4 |
| ACPE Number | 0107-0000-21-271-H01-T |
$9.00
